Evaxion Biotech A/S (EVAX) is a biotechnology company specializing in the development of immunotherapeutic treatment approaches in oncology and infectious diseases. The company focuses on developing personalized vaccines and treatment methods based on the analysis of patients' immune responses. Evaxion Biotech aims to innovate in diagnostics and therapy to enhance a patient's ability to fight against cancer and infections. Their approaches are based on utilizing modern technologies and data analytics. Shares of Evaxion Biotech A/S (EVAX) can be an interesting choice for investors tracking the biotechnology sector and innovations in the field of immunotherapy.